Medtronic Inc. (MDT)
the world’s largest maker of heart-maker devices, won U.S. regulatory approval for the first artificial pancreas system that automatically stops insulin delivery to diabetics when glucose levels reach a certain point.
The MiniMed 530G with Enlite was approved for use by people with diabetes who are at least 16 years old, the Minneapolis-based company said in a statement today.
The device’s improved accuracy and ability to shut itself off for two hours builds on existing machines, which sound an alarm when glucose levels get to a preset level.
© Copyright 2016 Bloomberg News. All rights reserved.